NEW YORK, April 3 - Myriad Genetics said today that it was tapped by DuPont to help the chemical giant's agbio division build a better seed.

Myriad will get $24 million over two years to apply its genomic-sequencing technology and bioinformatics experience to collect and deliver certain molecular-genetic information to the unit, Pioneer.

Financial details of the deal were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.